What is the potential role of antifibrotic agents for the treatment of liver disease?
Schnabl
Bernd
B
University of California, San Diego School of Medicine, San Diego, CA 92093-0602, USA.
Scholten
David
D
Brenner
David A
DA
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000473:pathology* / Q000503:physiopathology
D020533:Angiogenesis Inhibitors; D005343:Fibrinolytic Agents